|
|
Volumn 4, Issue 3, 2005, Pages 155-
|
|
Renal cell carcinoma: A new era?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AG 013736;
ALPHA INTERFERON;
HLA ANTIGEN;
INTERLEUKIN 2;
MITOGEN ACTIVATED PROTEIN KINASE;
PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;
PROTEIN TYROSINE KINASE INHIBITOR;
RAF PROTEIN;
SORAFENIB;
SUNITINIB;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR;
VON HIPPEL LINDAU PROTEIN;
ANGIOGENESIS;
CANCER SURVIVAL;
CELLULAR IMMUNITY;
CLEAR CELL CARCINOMA;
EDITORIAL;
GENE MUTATION;
GENE SILENCING;
HUMAN;
KIDNEY CARCINOMA;
PROGNOSIS;
TUMOR SUPPRESSOR GENE;
VHL GENE;
ADENOCARCINOMA;
GENETICS;
IMMUNOLOGY;
KIDNEY TUMOR;
NOTE;
ADENOCARCINOMA, CLEAR CELL;
CARCINOMA, RENAL CELL;
HUMANS;
KIDNEY NEOPLASMS;
|
|
EID: 33644933152
PISSN: 15587673
EISSN: None
Source Type: Journal
DOI: 10.3816/CGC.2005.n.026 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
